2018 News Archives
CBD Treatment Approved by FDA Could Carry Cannabis to Rescheduling
The FDA’s Center for Drug Evaluation and Research has approved the legal use of CBD for patients ages 2 and up who suffer from very specific conditions: Dravet Syndrome (DS) and Lennox-Gastaut Syndrome (LGS), two severe forms of childhood-onset epilepsy. With so much public support in the US for cannabis legalization – not just CBD legalization – the time is right for a major overhaul.
